within Pharmacolibrary.Drugs.ATC.D;

model D07AC15
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.14,
    Cl             = 150 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Beclometasone is a synthetic corticosteroid used primarily as an anti-inflammatory and immunosuppressant agent. It is commonly used for the treatment of asthma (as an inhaled formulation), allergic rhinitis, and various inflammatory skin disorders such as eczema and psoriasis (as a topical agent). It is an approved medication widely used today in both inhalational and topical forms.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters refer to healthy adult subjects after topical administration of beclometasone dipropionate. Data are based on literature estimates as no direct human PK study for topical beclometasone could be identified.</p><h4>References</h4><ol><li><p>Szefler, SJ (2001). Pharmacokinetics of intranasal corticosteroids. <i>The Journal of allergy and clinical immunology</i> 108(1 Suppl) S26–S31. DOI:<a href=&quot;https://doi.org/10.1067/mai.2001.115563&quot;>10.1067/mai.2001.115563</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11449203/&quot;>https://pubmed.ncbi.nlm.nih.gov/11449203</a></p></li><li><p>Naclerio, RM (1998). Optimizing treatment options. <i>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</i> 28 Suppl 6 54–59. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2222.1998.0280s6054.x&quot;>10.1046/j.1365-2222.1998.0280s6054.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9988437/&quot;>https://pubmed.ncbi.nlm.nih.gov/9988437</a></p></li><li><p>Doan, PL, &amp; Chao, NJ (2009). The role of oral beclometasone dipropionate in the treatment of gastrointestinal Graft-versus-Host Disease. <i>Drugs</i> 69(10) 1339–1350. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200969100-00004&quot;>10.2165/00003495-200969100-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19583452/&quot;>https://pubmed.ncbi.nlm.nih.gov/19583452</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D07AC15;
